cro.directory
← Compare landing

Axcelead Drug Discovery Partners, Inc. vs LIDE Biotech

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axcelead/lide-biotech

CategoryAxcelead Drug Discovery Partners, Inc.LIDE Biotech
Listed sitecrocro
SummaryAxcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • Specialized & Large-Animal Models
  • GLP Toxicology
  • Biomarker Assays
  • Flow Cytometry Services
  • Bioanalysis
  • Bioinformatics & Data Science
  • Genomics & Sequencing Services
  • Proteomics Services
  • Pathology & Histology Services
  • Translational Research
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Specialized & Large-Animal Models
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Genomics & Sequencing Services
  • Proteomics Services
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Biomarker Assays
Modalities
  • Small Molecule
  • Oligonucleotide
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Monoclonal Antibodies)
  • Peptide
  • mRNA
  • Antibody-Drug Conjugate (ADC)
  • Cell Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Nephrology
  • Metabolic
  • Cardiovascular
  • Oncology
  • Immunology
LocationsData not yet provided.
  • Headquarters, China
CertificationsData not yet provided.
  • AAALAC · Identifier: AAALAC accredited
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.